Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Cohen & Company Capital Markets Hires Connor Leahey to Lead ATM Practice

Cohen & Company Inc. (NYSE American:COHN) announced via press release on November 16, 2026 the launch of a dedicated At-the-Market offering practice within its Cohen & Company Capital Markets division, alongside the appointment of Connor Leahey as Managing Director to lead the new platform.

Shwetambri Chauhan | 16 November 2026

Hood River Capital Reports 8.05% Stake in Ucore Rare Metals

Hood River Capital Management LLC filed a Schedule 13G with the SEC on November 16, 2026, disclosing a beneficial ownership position in the common stock of Ucore Rare Metals Inc. as of September 30, 2026.

Manish Choudhary | 16 November 2026

Hood River Capital Exits New Era Energy & Digital Stake

Hood River Capital Management LLC filed an amended beneficial ownership statement with the SEC on November 16, 2026, disclosing that it holds zero shares of New Era Energy & Digital, Inc. common stock as of September 30, 2026.

Aakashdeep | 16 November 2026

Vivo Opportunity Cuts Bright Minds Stake to 3.8%

Vivo Opportunity Fund Holdings, L.P. and three affiliated entities filed Amendment No. 2 to a Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership of common stock in Bright Minds Biosciences Inc. as of September 30, 2026.

Manish Choudhary | 16 November 2026

Hood River Capital Reports 4.97% Stake in Butterfly Network

Hood River Capital Management LLC filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing a beneficial ownership position in Butterfly Network, Inc. common stock as of September 30, 2026.

Shwetambri Chauhan | 16 November 2026

Neos Partners Discloses 37.2% Stake in Forgent Power Solutions

A Schedule 13G (Amendment No. 2) was filed on November 16, 2026, by Neos Partners, LP and affiliated reporting persons, disclosing beneficial ownership positions in Forgent Power Solutions, Inc. as of September 30, 2026.

Anjali Anand | 16 November 2026

Vivo Opportunity Fund Discloses 9.99% Stake in SAB Biotherapeutics

Vivo Opportunity Fund Holdings, L.P. and affiliated entities filed Amendment No. 2 to a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership positions in SAB Biotherapeutics, Inc. as of September 30, 2026.

Aakashdeep | 16 November 2026

Surgery Partners Seeks Noteholder Consent Ahead of Spyglass Merger

Surgery Partners, Inc. filed a DEFA14A with the SEC on November 16, 2026, disclosing that its indirect wholly owned subsidiary, Surgery Center Holdings, Inc., has commenced a consent solicitation from holders of $1,225,000,000 in aggregate principal amount of 7.250% Senior Notes due 2032 in …

Vinay Lochav | 16 November 2026

Anette Schmid Files Schedule 13D/A No. 6 for SCHMID Group

Anette Schmid filed Amendment No. 6 to Schedule 13D with the SEC on November 16, 2026, disclosing beneficial ownership of 34,888,004 Class A Ordinary Shares of SCHMID Group N.V., representing 38.84% of the class, following a series of share distributions, capital increases, and debt-settlement …

Nitish Kishor | 16 November 2026

Verition Discloses 5.05% Stake in 1RT Acquisition Corp.

Verition Fund Management LLC and Nicholas Maounis filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 870,780 Class A ordinary shares of 1RT Acquisition Corp. as of September 30, 2026.

Aditi Sarkar | 16 November 2026
Support

Hi! How can we help you today?

Loading…